Cancer Communications
indexed by SCI
BMC


Editorial
In pursuit of a flawless aphrodite: paving the way to scarless oncoplastic breast surgery
Liling Zhu, Shunrong Li, Luyuan Tan, Xiaolan Zhang, Jiannan Wu, Fengxi Su, Kai Chen & Erwei Song
Cancer Communications 2019 39: 82
[Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 12/4/2019   doi:10.1186/s40880-019-0422-4
Original article
Bortezomib inhibits growth and sensitizes glioma to temozolomide (TMZ) via down-regulating the FOXM1-Survivin axis
Jun-Hai Tang, Lin Yang, Ju-Xiang Chen, Qing-Rui Li, Li-Rong Zhu, Qing-Fu Xu, Guo-Hao Huang, Zuo-Xin Zhang, Yan Xiang, Lei Du, Zheng Zhou & Sheng-Qing Lv
Cancer Communications 2019 39: 81
[Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 12/3/2019   doi:10.1186/s40880-019-0424-2
Original article
A nomogram for individualized estimation of survival among adult patients with adrenocortical carcinoma after surgery: a retrospective analysis and multicenter validation study
Jianqiu Kong, Junjiong Zheng, Jinhua Cai, Shaoxu Wu, Xiayao Diao, Weibin Xie, Xiong Chen, Chenyi Liao, Hao Yu, Xinxiang Fan, Chaowen Huang, Zhuowei Liu, Wei Chen, Qiang Lv, Haide Qin, Jian Huang & Tianxin Lin
Cancer Communications 2019 39: 80
[Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 11/27/2019   doi:10.1186/s40880-019-0426-0
Review
The immune landscape of esophageal cancer
Tu-Xiong Huang, Li Fu
Cancer Communications 2019 39: 79
[Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 11/26/2019   doi:10.1186/s40880-019-0427-z
Letter to the Editor
Long-lasting responses after discontinuation of nivolumab treatment for reasons other than tumor progression in patients with previously treated, advanced non-small cell lung cancer
Hideharu Kimura, Tomoyuki Araya, Taro Yoneda, Hiroki Shirasaki, Koji Kurokawa, Tamami Sakai, Hayato Koba, Yuichi Tambo, Shingo Nishikawa, Takashi Sone & Kazuo Kasahara
Cancer Communications 2019 39: 78
[Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 11/21/2019   doi:10.1186/s40880-019-0423-3
Review
Post-translational modification of Parkin and its research progress in cancer
Dan Ding, Xiang Ao, Ying Liu, Yuan-Yong Wang, Hong-Ge Fa, Meng-Yu Wang, Yu-Qi He & Jian-Xun Wang
Cancer Communications 2019 39: 77
[Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 11/21/2019   doi:10.1186/s40880-019-0421-5
Review
Interactions between cancer cells and bone microenvironment promote bone metastasis in prostate cancer
Xiangyu Zhang
Cancer Communications 2019 39: 76
[Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 11/21/2019   doi:10.1186/s40880-019-0425-1
Original article
Minimally invasive surgery alone compared with intensity-modulated radiotherapy for primary stage I nasopharyngeal carcinoma
You-Ping Liu, Xing Lv, Xiong Zou, Yi-Jun Hua, Rui You, Qi Yang, Le Xia, Shao-Yan Guo, Wen Hu, Meng-Xia Zhang, Si-Yuan Chen, Mei Lin, Yu-Long Xie, Li-Zhi Liu, Rui Sun, Pei-Yu Huang, Wei Fan, Xiang Guo, Ming-Huang Hong & Ming-Yuan Chen
Cancer Communications 2019 39: 75
[Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 11/15/2019   doi:10.1186/s40880-019-0415-3
Research highlight
Tumor mutational burden as a new biomarker for PD-1 antibody treatment in gastric cancer
Gunnar Folprecht
Cancer Communications 2019 39: 74
[Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 11/14/2019   doi:10.1186/s40880-019-0417-1
Study Protocol
Neoadjuvant stereotactic radiosurgery for intracerebral metastases of solid tumors (NepoMUC): a phase I dose escalation trial
hristian D. Diehl, Ehab Shiban, Christoph Straube, Jens Gempt, Jan J. Wilkens, Markus Oechsner, Carmen Kessel, Claus Zimmer, Benedict Wiestler, Bernhard Meyer & Stephanie E. Combs
Cancer Communications 2019 39: 73
[Abstract ]    [ PDF Full-text ]    [ HTML Full-text ]     [ PubMed]   Epub: 11/9/2019   doi:10.1186/s40880-019-0416-2

<<    Page 2 of 25  >>    




CJC Wechat 微信公众号


 

Editorial Manager


CC adopts ScholarOne Manuscripts to manage its submissions from Nov.1, 2019

 Submission Guidelines  

 

Reference style for  

 EndNote,
 Reference Manager



Editorial Manager


 

Year:

 

Month:

Advanced search

Subscription


CC is now published by Wiley

© Cancer Communications

651 Dongfeng Road East, Guangzhou 510060, P. R. China